13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 17 holding rows worth $182,698,000.
- Accession
- 0001085146-21-003225
- Filer
- CIK 1544773
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 17 entries on the cover page, a total value of $182,698,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $182,698,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 487,327 | $58,177,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 589,100 | $45,137,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 157,838 | $29,134,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 305,994 | $19,412,000 | thousands by filing date | |
| Surrozen, Inc. | 86889P109 | COM | 1,000,000 | $6,718,000 | thousands by filing date | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 178,787 | $3,729,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITN CORP | G31658100 | CLASS A ORD SHS | 300,000 | $2,964,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 300,000 | $2,955,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 300,000 | $2,927,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 300,000 | $2,925,000 | thousands by filing date | |
| OLINK HLDG AB | 680710100 | ADR | 115,425 | $2,799,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP II | G6882C106 | COM | 200,000 | $1,953,000 | thousands by filing date | |
| CASI PHARMACEUTICALS INC | 14757U109 | COM | 1,563,003 | $1,860,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 150,000 | $1,489,000 | thousands by filing date | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 333,333 | $361,000 | thousands by filing date | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 45,960 | $134,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 33,331 | $24,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-21-003225 | this filing | 2021-11-15 | acceptance time not in the bulk data set |